Detection of bla-AIM Metallo Beta Lactamase Gene among Stenotrophomonas Maltophilia and Carbapenem Resistant Pseudomonas Aeruginosa Isolated from Various Infections in AL- Najaf Province
Enas Jalil Baqer AL-Mayali, S. Al-Muhanna, Israa Abdul Ameer Al-Kraety
{"title":"Detection of bla-AIM Metallo Beta Lactamase Gene among Stenotrophomonas Maltophilia and Carbapenem Resistant Pseudomonas Aeruginosa Isolated from Various Infections in AL- Najaf Province","authors":"Enas Jalil Baqer AL-Mayali, S. Al-Muhanna, Israa Abdul Ameer Al-Kraety","doi":"10.21931/rb/2024.09.01.61","DOIUrl":null,"url":null,"abstract":"Stenotrophomonas maltophilia is a \"rapidly evolving pathogen of concern\" that is increasingly being identified. The World Health Organization also recognizes it as one of the hospitals' most significant multi-drugresistant pathogens. Also, Pseudomonas aeruginosa is an opportunistic human pathogen that causes most\nhealthcare-associated infections, and it is considered a paradigm of antibiotic resistance development. In many\nhospitals across the globe, carbapenem-resistant Pseudomonas aeruginosa has emerged as a significant source\nof infection. The present study aimed to study the isolation and diagnosis of S. maltophilia and P. aeruginosa\nfrom different clinical samples, evaluate the occurrence of carbapenem resistance of P. aeruginosa isolated\nfrom clinical samples, and investigate the dissemination of the bla-AIM genes between these isolates. Eight\nhundred fifty specimens were collected from various clinical samples between 2022 and 2023. The specimens\nincluded 220 swabs (burn), 200 (urine), 140 (stool), and 130(wound). 90 (ear),50 (throat), 10 (Cerebrospinal\nfluid), and 10 (blood). Represented by 680 specimens contained bacterial growth, and 170 specimens had no\nbacterial growth. Out of the 680 bacterial growth isolates, 410 revealed growths of Gram-negative bacteria,\nand 270 were Gram-positive bacteria. On MacConkey ag, ar 180/410 bacteria were lactose ferment; other\nisolates, es 230/410 of the isolates were lactose non-fermented bacteria. In a cross-sectional manner, Stenotrophomonas maltophilia and Pseudomonas aeruginosa isolates during this period were isolated and identified\ndepending on the primary methods of diagnosis, then the use of the VITEK-2 compact system. The results\nshowed 42 isolates of S. maltophilia and 80 isolates of P. aeruginosa from total Gram-negative bacteria. The\nresults show that only five isolates contained the AIM gene, with a percentage of (10.4 %) of the 48 Carbapenem Resistant Pseudomonas aeruginosa isolates, five isolates from 42 S. maltophilia contain the AIM\ngene with a percentage (11.9%), based on the Polymerase chain reactions assay.\nKeywords: Stenotrophomonas maltophilia, Carbapenem Resistance, Pseudomonas aerginosa.","PeriodicalId":505112,"journal":{"name":"Bionatura","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bionatura","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21931/rb/2024.09.01.61","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Stenotrophomonas maltophilia is a "rapidly evolving pathogen of concern" that is increasingly being identified. The World Health Organization also recognizes it as one of the hospitals' most significant multi-drugresistant pathogens. Also, Pseudomonas aeruginosa is an opportunistic human pathogen that causes most
healthcare-associated infections, and it is considered a paradigm of antibiotic resistance development. In many
hospitals across the globe, carbapenem-resistant Pseudomonas aeruginosa has emerged as a significant source
of infection. The present study aimed to study the isolation and diagnosis of S. maltophilia and P. aeruginosa
from different clinical samples, evaluate the occurrence of carbapenem resistance of P. aeruginosa isolated
from clinical samples, and investigate the dissemination of the bla-AIM genes between these isolates. Eight
hundred fifty specimens were collected from various clinical samples between 2022 and 2023. The specimens
included 220 swabs (burn), 200 (urine), 140 (stool), and 130(wound). 90 (ear),50 (throat), 10 (Cerebrospinal
fluid), and 10 (blood). Represented by 680 specimens contained bacterial growth, and 170 specimens had no
bacterial growth. Out of the 680 bacterial growth isolates, 410 revealed growths of Gram-negative bacteria,
and 270 were Gram-positive bacteria. On MacConkey ag, ar 180/410 bacteria were lactose ferment; other
isolates, es 230/410 of the isolates were lactose non-fermented bacteria. In a cross-sectional manner, Stenotrophomonas maltophilia and Pseudomonas aeruginosa isolates during this period were isolated and identified
depending on the primary methods of diagnosis, then the use of the VITEK-2 compact system. The results
showed 42 isolates of S. maltophilia and 80 isolates of P. aeruginosa from total Gram-negative bacteria. The
results show that only five isolates contained the AIM gene, with a percentage of (10.4 %) of the 48 Carbapenem Resistant Pseudomonas aeruginosa isolates, five isolates from 42 S. maltophilia contain the AIM
gene with a percentage (11.9%), based on the Polymerase chain reactions assay.
Keywords: Stenotrophomonas maltophilia, Carbapenem Resistance, Pseudomonas aerginosa.